Mounjaro weight loss Injection Pen

What is Mounjaro and what is it used for?

Mounjaro is a prescription weight loss medication that comes in the form of a weekly injectable pen. It contains the active ingredient tirzepatide, originally developed to treat type 2 diabetes. In addition to improving blood sugar control, Mounjaro has been shown to help adults with obesity or overweight lose significant weight. In late 2023 it was approved in the UK for weight management in adults with a BMI of 30 or above, or 27–30 with weight-related health conditions (such as high blood pressure, high cholesterol, heart disease or prediabetes). It is intended to be used alongside a reduced-calorie diet and increased physical activity to support long-term weight lossgov.uk.

In summary, Mounjaro is a weekly weight loss injection for adults who struggle with excess weight, including those who may also have weight-related conditions or type 2 diabetes. It is only available via prescription (through specialist NHS services or private clinics) after a healthcare professional determines it’s appropriate for you. This medication offers a new option for people who have not achieved sufficient weight loss with diet and exercise alone, providing an additional tool to help manage obesity.

How does Mounjaro work?

Mounjaro’s active ingredient, tirzepatide, is a dual-action incretin mimetic – it activates two natural hormone pathways in your body to help with weight regulation:

• GLP-1 receptor agonist: Tirzepatide mimics glucagon-like peptide-1 (GLP-1), a hormone released in your gut when you eat. GLP-1 signals your brain to reduce appetite, makes you feel full, and slows down stomach emptying. By acting on GLP-1 receptors, Mounjaro helps prevent overeating and curbs cravings, so you feel satisfied with smaller meals.

• GIP receptor agonist: Tirzepatide also mimics glucose-dependent insulinotropic polypeptide (GIP), another gut hormone. GIP works on the brain and fat cells to regulate energy balance and enhance the effects of GLP-1. Through GIP, Mounjaro further suppresses appetite and improves how your body processes sugar and fat.

By combining these two actions, Mounjaro can lead to greater weight loss than medications that work on GLP-1 alone. Essentially, it helps reset your body’s appetite signals: you feel full sooner and stay full longer, making it easier to eat less. It also helps stabilize blood sugar levels, which can reduce hunger spikes and may benefit those with diabetes. Many patients describe feeling fewer food thoughts and an ability to stick to smaller portions while on Mounjarogov.uk. Over time, this calorie reduction leads to weight loss.

Importantly, Mounjaro is not a stimulant or traditional appetite suppressant – it works hormonally and gradually. You won’t feel a sudden jolt; instead, you’ll notice subtle changes such as reduced hunger and prolonged fullness after mealsgov.uk. This mechanism, together with healthy eating and activity, creates a steady weight loss effect.

Who can use Mounjaro?

Mounjaro is indicated for adults (18 years and older) who need to lose weight for health reasons. The UK license and guidelines define the eligible groups as follows:

• People with obesity: Adults with a body mass index (BMI) of 30 or higher can be considered for Mounjaro for weight management. This typically includes those who are roughly 3 or more stone overweight for their height.

• People who are overweight with health issues: Adults with a BMI between 27 and 30 may also qualify if they have at least one weight-related health condition. Examples include type 2 diabetes, high blood pressure, high cholesterol, heart disease, sleep apnoea, or fatty liver disease. In these cases, losing weight can significantly improve or even resolve those conditions, so medication can be justified.

• Patients with type 2 diabetes and excess weight: Tirzepatide was first used in diabetes care, so diabetics with overweight/obesity especially may benefit doubly – better glucose control and weight loss. (Note: If you have type 1 diabetes, Mounjaro is not suitable for you.)

Doctors will generally prescribe Mounjaro only if weight loss is medically advised – for example, if your weight is causing health problems or if losing weight would reduce your health risks. It’s usually considered when diet, exercise, and behavioral changes alone have not achieved sufficient weight loss. You do not need to be in a hospital or specialist service to get Mounjaro; it can be prescribed in the community (including through private online clinics like MedCare) after an appropriate assessment.

Before starting, a healthcare provider will evaluate your medical history, current medications, and make sure you meet the criteria. You’ll typically be asked about what weight loss methods you’ve tried so far and whether you’re committed to continuing healthy lifestyle changes alongside the injections. Motivation and engagement in a weight loss plan are important, as Mounjaro works best with sustained improvements in diet and activity.

Summary of who can use it:

• Adults with BMI ≥ 30, or BMI ≥ 27 with a related health conditiongov.uk.

• Typically those who have already attempted lifestyle weight loss.

• Patients who are not achieving adequate weight loss through diet/exercise alone and need medical help.

• It can be used whether or not you have diabetes (if you do have diabetes, your doctor will manage Mounjaro as part of your diabetes treatment plan).

Always follow your prescriber’s guidance. If you’re unsure whether you qualify, you can speak to our pharmacist or GP – they will calculate your BMI and discuss your health background to determine if Mounjaro is appropriate for you.

(For NHS patients, NICE guidelines currently recommend tirzepatide for people with a BMI of 35+ plus a comorbidity, under specialist supervisionncbi.nlm.nih.gov. However, private services may prescribe within the broader BMI ≥30 license if it’s clinically appropriate. In any case, a doctor’s assessment is required.)

Who should not use Mounjaro?

While Mounjaro is effective for many, it isn’t suitable for everyone. You should not use Mounjaro (or need special caution) in the following situations:

• Pregnancy: Do not use Mounjaro if you are pregnant or trying to conceive. Weight loss medications can potentially harm an unborn baby. Women of childbearing age should use effective contraception while on Mounjaro. If you plan to become pregnant, you’ll need to stop Mounjaro at least 1 month before trying to conceive to ensure the drug is fully out of your system. Similarly, it should not be used during pregnancy.

• Breastfeeding: Mounjaro is not recommended for breastfeeding mothers. It’s unknown if tirzepatide passes into breast milk, so out of caution mothers should avoid this medication while nursing (or avoid nursing while on the medication).

• Allergy: Do not use Mounjaro if you’ve ever had an allergic reaction to tirzepatide or any of the ingredients in the injection. Signs of an allergy might include rash, itching, swelling, or difficulty breathing after a previous dose (see side effects section for more on serious allergic reactions).

• Medullary Thyroid Cancer (MTC) or MEN2: If you or an immediate family member have a history of medullary thyroid carcinoma (a rare thyroid cancer) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), you must not use Mounjaro. This class of medication has been associated with thyroid C-cell tumors in animal studies, so as a precaution it’s contraindicated for people with these specific genetic thyroid conditions.

• Past Pancreatitis: If you have had pancreatitis (inflammation of the pancreas) in the past, inform your doctor. Active or history of pancreatitis is a caution for Mounjaro. Your doctor might decide not to prescribe it or will monitor you very closely, since drugs like this have been linked (rarely) to pancreatitis. Mounjaro should be discontinued if pancreatitis is suspected or diagnosed.

• Severe Gastrointestinal Problems: Mounjaro slows stomach emptying, so it is not advised in people with severe digestive disorders, such as severe gastroparesis (a condition where the stomach doesn’t empty normally) or severe gastro-oesophageal reflux disease that isn’t controlled. If you have inflammatory bowel disease or other serious gut motility issues, your doctor will evaluate the risks and may avoid this medication.

• Children and Adolescents: Safety and effectiveness in those under 18 are not established, so Mounjaro is not licensed for children or teens.

• Combination with similar medications: You generally should not use Mounjaro alongside other GLP-1 agonist medications (such as semaglutide/Ozempic/Wegovy or liraglutide/Saxenda) or other weight-loss drugs at the same time, unless specifically directed by a specialist. Using multiple weight loss treatments together hasn’t been studied and could increase side effects. If you are already on a medication for diabetes like a DPP-4 inhibitor (e.g., sitagliptin) or another weekly injection, your prescriber will usually ask you to stop those before starting Mounjaro to avoid duplication.

• Other medical conditions: It’s important to disclose all your medical conditions to the prescribing clinician. Certain conditions might require caution or dose adjustments. For example, if you have kidney or liver problems, Mounjaro can still be used but your doctor might monitor you a bit more closely, especially if you become dehydrated from side effects. There’s no specific dose adjustment for kidney or liver impairment, but limited experience in very severe cases means caution is warranted. Likewise, if you have diabetic eye disease (retinopathy), rapid improvements in blood sugar from any diabetes medication can (rarely) worsen eye issues temporarily – so an eye check-up is sensible if you’re diabetic and starting Mounjaro.

Always provide a full medical history to your doctor or pharmacist before using Mounjaro. During our consultation, you will be asked about these factors. This is to ensure it’s safe for you. If Mounjaro isn’t suitable, the clinician will discuss alternatives.

What results can you expect with Mounjaro?

Mounjaro is considered one of the most effective weight loss medications available, but results vary from person to person. Here’s what to expect in terms of weight loss timeline and outcomes:

• Onset of weight loss: You won’t lose weight overnight, but many people start to notice some weight reduction within the first few weeks to a month of treatment. Clinical experience suggests that patients often see a few pounds come off after the first couple of doses once their appetite decreases. In trials, weight loss with Mounjaro typically began in the first 4 weeks and continued steadily thereafter

• Three to Six Months: By 3 months (12 weeks) into treatment – which often corresponds to being at ~5 mg dose – patients usually have achieved meaningful weight loss. A common goal is to lose at least 5% of your starting weight by around 3–6 months. Many achieve more. (For example, someone who started at 100 kg might aim for at least a 5 kg loss in that timeframe.) In fact, trials have shown much higher averages as dose increases, but 5% in 3–6 months is a threshold doctors look for to ensure the medication is working sufficientlyncbi.nlm.nih.gov.

• One year and beyond: The major clinical trials for tirzepatide (called SURMOUNT-1 and SURMOUNT-2) ran for 72 weeks (~18 months). The results were very promising:

  • In a trial of obese adults without diabetes, the average weight loss was about 16% of body weight on a 5 mg dose, 21% on 10 mg, and 22.5% on 15 mg, after 72 weeksgov.uk. By comparison, those on placebo (diet and exercise only) lost only ~2–3%. To put that in context, a person who weighed 100 kg could lose roughly 16–22 kg on Mounjaro over ~1.5 years, versus 2–3 kg with lifestyle changes alone.

  • In a trial of overweight adults with type 2 diabetes (who generally lose weight a bit more slowly), the average weight loss was about 13.4% on 10 mg and 15.7% on 15 mg over 72 weeksgov.uk. Diabetic patients tend to have slightly less weight loss on these medications, but still far more than those on placebo (~3% in that study).

  These numbers (15–22% weight reduction) are remarkable – for comparison, older weight loss medications or even some types of bariatric (weight loss) surgery often produce ~5–10% and ~20–30% loss respectively. Mounjaro, especially at higher doses, is approaching the effectiveness of gastric sleeve surgery in terms of percentage body weight lost.

• Typical patient experience: Not everyone will lose 20% of their weight – some lose more, some less. Factors such as your starting weight, diet and exercise efforts, and individual response play a role. Most patients can expect at least a 10% body weight loss with continued use, if they tolerate the medication and stick with lifestyle changes. Achieving >15% weight loss is a realistic possibility for many on the full dose. Many patients report that weight comes off steadily each week or month, rather than all at once. It’s common to see a quicker drop in the first few months (as you go from 2.5 to 5 to 7.5 mg, etc.), then the rate of weight loss might plateau somewhat and then improve again as doses increase. Your healthcare team may set incremental targets (e.g., 5% at 3 months, 10% at 6 months, etc.) and will monitor your progress.

• Beyond 18 months: There isn’t long-term (>2 years) data yet since the medication is new, but it appears that continuing the injections helps maintain and potentially increase weight loss up to a point. However, once you reach a healthy target or maximum tolerated dose, your doctor may keep you on that maintenance dose. Some patients might take Mounjaro for several years under medical supervision if needed to maintain their healthier weight, similar to how blood pressure or diabetes medications are used long-term.

• Lifestyle is key: The best results occur with concurrent lifestyle modifications. In trials, all participants were on a diet and exercise program alongside the injections. You will be encouraged to follow a reduced-calorie diet (for example, reducing portion sizes and cutting down on high-fat, high-sugar foods) and to increase physical activity (like regular walking, gym sessions, etc.). Mounjaro makes this easier by controlling appetite, but the effort you put into healthy habits will enhance your weight loss and help you feel better overall. Many people find that as they lose weight, they become more energetic and able to exercise, which further helps weight management.

• Expectation setting: It’s important to maintain realistic expectations. Weight loss is gradual with Mounjaro – think of it as a steady, sustainable decline rather than a crash diet. A loss of 1–2 pounds per week is a common trajectory after the first month or so, though it can vary. There may be weeks with no change on the scale – this is normal. Over months, the trend should be downward. Your clinic may schedule check-ins (for example at 6 months) to ensure the medication is benefiting you sufficiently. If not, they might reassess the treatment planncbi.nlm.nih.gov.

• Maintaining weight loss: One crucial thing to know is that if Mounjaro is stopped, some people do experience weight regain over time – as often happens when any weight loss treatment is discontinued. The hormone influences will fade, and appetite may return to prior levels. This is why it’s intended for long-term use, and why cultivating lasting diet and exercise habits is so important. After stopping, continuing with healthy lifestyle changes is essential to keep the weight off. (Researchers are also studying maintenance strategies – some patients might switch to a different maintenance medication or a lower dose, but these decisions are made on an individual basis.)

In summary, you can expect meaningful, health-improving weight loss with Mounjaro, on the order of several stone over the first year for many patients. The journey will be gradual and requires partnership – the medication will control hunger, but you’ll still need to make healthy food choices and stay active. Most patients find that Mounjaro helps them feel in control of their eating for the first time in a long while, allowing them to consistently maintain a calorie deficit without the usual constant cravings. Over time, this leads to substantial weight reduction, which can improve blood pressure, blood sugar, cholesterol, joint pain, and overall well-being.

(Always follow up with your healthcare provider for regular progress reviews. They will check how you’re responding to Mounjaro and can adjust your plan as needed.)

How is Mounjaro used?

Mounjaro is administered by injection, but don’t let this put you off – it’s designed to be user-friendly, and you do not need to draw up any liquid or use a traditional syringe. Mounjaro comes in a disposable pre-filled pen device (called the Mounjaro KwikPen). Here’s how it’s used:

• Frequency: You inject Mounjaro once a week on the same day each week. For example, you might choose every Monday. It should be roughly at the same time of day each week, but exact timing isn’t critical. Pick a day that will be easy to remember and stick to. Consistent weekly dosing helps maintain steady levels of the medication in your body.

• Injection method: The pen is injected subcutaneously (this means into the fatty layer just under the skin, not into muscle or veins)gov.uk. You do not need to inject into a vein. Common injection sites are:

  • Abdomen (stomach area): Usually at least a couple of inches away from the belly button.

  • Thigh: The front of your thigh, in the mid-thigh area.

  • Upper arm: The back or side of your upper arm (this site is a bit harder to self-inject; some patients have a family member or friend administer in the arm, or they stick to thigh/abdomen for self-injection).

  You should rotate injection sites each week (for example, alternate between left/right sides or different areas of the abdomen) to minimize any skin irritation.

• Pen usage: The Mounjaro pen is quite straightforward. Each pen is pre-loaded with the exact dose of medication. When you’re ready, you attach a new needle (if not already integrated), press the pen against your skin at the injection site, and push the button. The injection only takes a few seconds. The pen has a safety mechanism so the needle retracts after use. You will hear a click or two during the injection – one when it starts and one when it’s done – and a window on the pen will indicate that the dose has been delivered. The needles are very fine (much thinner than blood test needles), so most people feel minimal discomfort – often just a small pinch.

• Training: If you’re prescribed Mounjaro through our clinic or any service, you will receive full instructions on how to use it properly. This may include a demonstration by a nurse or pharmacist, or a link to an official video tutorial. The first injection can be done under supervision if you’re nervous. However, most patients find it easy after learning once. The key steps are: clean the skin with an alcohol swab, remove pen cap, pinch the skin, press pen to skin at 90 degrees, click the button, hold for about 10 seconds until the dose is delivered, then remove. Always read the Patient Information Leaflet’s injection instructions as well, to familiarize yourself with the device.

• With or without meals: It doesn’t matter what time of day you inject or whether you’ve eaten. Pick a time that you can consistently do each week. Some prefer bedtime to sleep through any mild nausea, others prefer morning. Either is fine as long as it’s roughly the same day each week.

• Missed dose: If you forget your weekly dose, check the leaflet or call your pharmacist for advice. In general, if you remember within 4 days (96 hours) of the missed injection, you can take the dose late and then resume your weekly schedulemedicines.org.uk. If more than 4 days have passed, skip the missed dose and just inject the next dose at your regular scheduled daymedicines.org.uk. Do not double dose to make up for a missed one. There must be at least 3 days (72 hours) between dosesmedicines.org.uk. Keeping a medication diary or setting reminders on your phone can help prevent missed doses.

• Continuing treatment: Mounjaro is meant for ongoing use. Do not stop it abruptly without talking to your doctor. If you stop, your blood sugar (if diabetic) can rise againmedicines.org.uk and your appetite may increase, potentially leading to weight regain. If you ever need to pause (due to side effects or an intercurrent illness), consult your healthcare provider on how to do so safely.

• Other tips: Always inspect the pen before use – the solution inside should be clear and free of particles. Don’t use it if it looks cloudy or discolored. Also, use a new needle for each injection (if the pen uses separate needles). After injecting, dispose of the used pen safely (see Storage and handling below for disposal instructions).

Many people are new to self-injection, so it’s normal to be a bit anxious at first. Rest assured, Mounjaro’s pen is designed for patients to use at home with minimal hassle. After the first one or two times, it will likely become a quick routine each week.

Mounjaro dosage schedule

To maximize effectiveness and minimize side effects, Mounjaro’s dosing is done in stages (titration). You will start at a low dose and gradually work up to a higher dose over a period of weeks. This allows your body to get used to the medication. The typical dosage schedule is:

• Starting dose – 2.5 mg: All patients begin with 2.5 mg once weeklygov.uk. You will take 2.5 mg weekly for the first 4 weeks (one month). This starter dose is primarily to allow your gastrointestinal system to adjust and to gauge your tolerance. Weight loss can occur on 2.5 mg, but it’s usually modest at this stage; think of it as preparing your body for the higher doses.

• First increase – 5 mg: After 4 weeks on 2.5 mg, you will typically increase to 5 mg once weeklygov.uk. You’ll continue at 5 mg for at least another 4 weeks. Many patients already notice suppressed appetite and some weight loss at 5 mg. If side effects at 5 mg are manageable, you’ll likely move up again.

• Further titration: After that, the dose can be increased in 2.5 mg increments no more frequently than every 4 weeks, depending on your individual needs and tolerability. The available pen strengths after 5 mg are:

  • 7.5 mg once weekly – (optional intermediate step for finer titration)

  • 10 mg once weekly

  • 12.5 mg once weekly – (another intermediate step, if needed)

  • 15 mg once weekly – this is the maximum dose for Mounjarogov.uk.

  Not everyone will go through every increment; some regimens skip the 7.5 mg and 12.5 mg steps, but many clinicians do use them if needed to improve tolerance. For example, a common schedule might be: 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg, each for 4 weeks. However, if you’re doing well at 10 mg and still losing weight, your doctor might keep you there for longer or only move to 15 mg if needed. The dose increases are individualized.

• Maintenance dose: The goal is to find a dose that you can comfortably stay on long-term that effectively controls your appetite and supports weight loss. For some people this is 5 mg, for others 10 mg, and many go to 15 mg if they tolerate it well. There isn’t one “correct” maintenance dose – it depends on your response. The higher doses tend to produce more weight loss on average, but also a bit more side effects, so it’s a balance. Your doctor will work with you to determine the optimal dose. It might take a few months to reach it.

• Do not rush the titration: It’s very important to follow the schedule your healthcare provider gives and not jump to a higher dose faster than recommended. Increasing too quickly raises the risk of side effects like nausea. If you experience significant side effects at a given dose, the doctor might delay the next increase or even reduce the dose temporarily. There’s flexibility – some patients stay 8 weeks on a step instead of 4, to allow more time to adjust. The motto is “go low and slow” to ensure you can stay on the medication successfully.

• If you miss a dose increase: For instance, if you were due to go from 5 mg to 7.5 mg but you’re still feeling quite nauseous, your doctor might advise remaining on 5 mg for an extra month. This is okay. The titration schedule isn’t set in stone if your body needs a bit longer. Conversely, do not increase the dose on your own without approval.

In summary, Month 1 is 2.5 mg, Month 2 is 5 mg, then gradually upward, reaching possibly 15 mg by around Month 5 or 6 if indicated. Once on a maintenance dose, you’ll continue weekly injections at that level.

Clinical trials and practice have shown that this stepwise approach maximizes weight loss while keeping the treatment tolerable. By the time you reach higher doses, many of the early side effects will have subsided. Always adhere to the dosing instructions given by your prescribing clinician – they reflect the latest guidance and your personal circumstances.

(For reference, the MHRA-authorised dosing guidelines stipulate starting at 2.5 mg weekly for 4 weeks, then 5 mg for ≥4 weeks, and that doses may be upped every 4 weeks up to 15 mg maxgov.uk. Intermediate 7.5 mg and 12.5 mg pens exist to fine-tune the increments. Most common maintenance doses in practice are 10 or 15 mg weekly.)

Possible side effects

Like any medication, Mounjaro can cause side effects. It’s important to know that most side effects are mild-to-moderate and tend to happen early in treatment or after a dose increase – they often improve over time as your body adaptsema.europa.eugov.uk. Also, not everyone gets them. We will cover common side effects first, then serious but less common ones.

Very common side effects (may affect more than 1 in 10 people):

• Gastrointestinal (GI) symptoms: The majority of Mounjaro’s common side effects are related to the digestive systemgov.uk. This is a consequence of how it works (slowing gastric emptying, etc.). These include:

  • Nausea – feeling sick to your stomach. This is the number one side effect. It’s usually mild and transient for most patientsema.europa.eu. It tends to be worst in the first day or two after an injection, especially when you’re new to a dose. Many people find it fades after a couple of weeks on the same dose.

  • Vomiting – actually being sick (throwing up). Not everyone who feels nauseated will vomit; in fact, most do not. If vomiting occurs, it’s typically occasional. Staying hydrated and eating bland foods can help. This usually gets better as tolerance buildsema.europa.eu.

  • Diarrhoea – loose or more frequent bowel movements. This can happen as your digestion slows and food moves differently through your gut. It’s generally mild and short-lived. Again, keep hydrated and watch for any signs of dehydration.

  • Constipation – some people instead experience the opposite: constipation. Slower stomach emptying can lead to slower bowel movements for some. Drinking plenty of water, eating fibre (or using a fibre supplement), and staying active can mitigate this.

  • Stomach pain or discomfort – you might feel early satiety (a sense of fullness or pressure in the upper stomach) or mild abdominal cramps. Some experience indigestion/heartburn or bloating. These are usually due to your stomach emptying slower than before, causing a feeling of fullness. Over-the-counter antacids or simethicone (for gas) can help if approved by your doctor.

  Note: These GI side effects are most common during the dose-escalation phase (when you increase from 2.5 to 5 to 7.5, etc.)ema.europa.eu. In the clinical trials, many people had some nausea at first, but the incidence dropped over time and with continued useema.europa.eu. Only a small percentage had to stop the medication due to GI side effects. Following the prescribed titration schedule (not jumping doses) is key to keeping these manageable. If you do experience nausea or other GI issues, let your healthcare provider know – they can advise remedies. Common suggestions include eating smaller, more frequent meals, avoiding very rich or greasy foods (which can worsen nausea), and staying upright after eating to reduce reflux. Most patients say these side effects are “annoying but tolerable” and improve after the first few weeks.

Common side effects (may affect up to 1 in 10 people):

• Loss of appetite: Given how Mounjaro works, it’s no surprise that many people feel less hungry. This is essentially the desired effect, but it’s listed as a side effect in the leaflet. You might find you get full much faster than before and sometimes have to remind yourself to eat balanced meals. Ensure you still nourish yourself with healthy foods even if your appetite is lower.

• Dizziness or lightheadedness: A small number of patients report feeling a bit dizzy, especially when getting up quickly. This could be due to slight drops in blood pressure (which can happen as you lose weight or from dehydration). Make sure to stand up slowly if you experience this. Staying hydrated and having a little healthy snack can help if you feel lightheaded.

• Fatigue: You might feel a bit more tired or low-energy on some days, particularly early on. This often improves as your body adjusts and as you lose weight (when many people actually start feeling more energetic). Ensure you’re getting enough nutrients; severe calorie restriction beyond what is recommended could lead to fatigue, so don’t overly starve yourself – follow the nutrition plan given by your provider.

• Headache: Some individuals have mild headaches. Normal pain relievers like paracetamol can be used if needed (assuming no contraindications for you).

• Injection site reactions: Because it’s an injection, occasionally there can be some redness, itching, or a small lump at the injection site. This is usually mild and goes away in a day or two. Rotate sites to minimize this. If you have a lot of irritation, let your doctor know; they might check your technique or advise an antihistamine if appropriate.

• Stomach reflux or heartburn: Some patients experience acid reflux (GERD) symptoms or burping/flatulence due to slower digestion. Avoiding large meals and not lying down right after eating can reduce reflux. Over-the-counter heartburn remedies might be used if your doctor approves.

• Change in taste: A few people notice food doesn’t taste the same or they have an odd taste in their mouth. This isn’t very common, but changes in taste can occur with GLP-1 medications. It can contribute to eating less (e.g., finding sweet foods less appealing).

• Hair thinning: Some patients in weight loss trials of Mounjaro reported hair loss or thinning. This is not due to the drug attacking hair, but likely due to the rapid weight loss and associated changes in nutrition/hormones (a phenomenon seen in many weight loss methods, including dieting or surgery). It usually occurs 3–6 months into treatment. The hair loss is typically temporary – hair will regrow once your weight stabilizes and your body adapts. Ensuring you eat sufficient protein and vitamins can help minimize this. If you notice significant hair shedding, mention it at your review; your doctor can check your thyroid and nutritional status just in case.

• Low blood sugar (hypoglycaemia): For non-diabetic patients, this isn’t a concern as Mounjaro by itself rarely causes low sugar. However, if you have diabetes and are on other blood sugar-lowering medicines (such as insulin or sulfonylureas), there is a risk of your blood sugar going too low. Symptoms of hypoglycemia can include shakiness, sweating, fast heartbeat, hunger, confusion, or headache. Your doctor will likely reduce doses of those other medications when starting Mounjaro to mitigate this. Always have a quick source of sugar (like glucose tablets or sweets) if you are diabetic and check your blood sugars as directed. If you’re not diabetic, true hypoglycemia is very unlikely, though some people feel a bit shaky if they haven’t eaten – usually solved by having a small snack.

• Mild blood pressure drop: As mentioned, in patients with obesity and conditions like obstructive sleep apnoea, some drop in blood pressure was observed (likely due to weight loss effect). This is usually beneficial if you have high blood pressure, but if you are on blood pressure medications, keep an eye on it to ensure it doesn’t go too low as you lose weight (your GP might need to adjust your BP meds over time).

Uncommon but important side effects (may affect up to 1 in 100 or rarer):

• Pancreatitis (acute pancreatitis): This is a rare but serious side effect associated with GLP-1 medications. In studies, tirzepatide was not found to significantly increase pancreatitis risk compared to placebo, but since other drugs in this class have had rare cases, it’s something to be aware of. Pancreatitis is an inflammation of the pancreas that causes severe abdominal pain, often stabbing pain that can radiate to the back, sometimes accompanied by vomiting and inability to tolerate food. The pain is persistent (does not go away)medicines.org.uk and typically becomes very intense. If you experience severe stomach pain that won’t stop, especially if you’re vomiting or it’s reaching through to your back, you should seek medical attention immediately Blood tests and scans can diagnose pancreatitis. If pancreatitis is confirmed, Mounjaro would be stopped and not started again. This side effect is uncommon, but because it’s serious, always err on the side of caution and get checked if you have these symptoms.

• Gallbladder problems (gallstones or cholecystitis): Significant weight loss can increase the risk of gallstones forming. There were slightly higher reports of gallbladder events in weight loss trials of tirzepatide (a small percentage of patients)ema.europa.eu, often correlated with the amount of weight lost. Gallstones can sometimes lead to cholecystitis (inflammation of the gallbladder). Symptoms to watch for are sharp pain in the upper right abdomen, possibly radiating to the right shoulder, especially after a fatty meal, and sometimes accompanied by nausea. If a gallstone blocks a duct, you might also get jaundice (yellowing of skin or eyes) or very dark urine. If you get symptoms suggesting gallstones or gallbladder attack, see a doctor. Treatments range from observation to medications to break stones, or in some cases surgical removal of the gallbladder. The overall risk is not high, but it’s something to be mindful of during rapid weight loss.

• Kidney injury: This is not a direct effect of the drug, but can occur secondary to severe dehydration from prolonged vomiting or diarrhoea. If you were to have persistent GI symptoms and couldn’t keep fluids down, dehydration could strain your kidneys (in rare cases leading to acute kidney injury). That’s why maintaining hydration is important. If you find you can’t drink fluids due to nausea/vomiting, contact a healthcare provider; you might need temporary measures like IV fluids or anti-sickness medication.

• Severe allergic reaction (anaphylaxis): This is very rare, but as with any medication, some people could have a serious allergy. Signs include swelling of the face, lips, tongue or throat, difficulty breathing, wheezing, feeling faint, rash or hives, and a rapid heartbeat. Anaphylaxis would usually occur shortly after injection. If you ever have these symptoms, call emergency services immediately, as it’s a medical emergency. Do not use Mounjaro again. (In clinical use, such reactions to tirzepatide are exceedingly uncommon, but have been reported in a small number of patients.)

• Increased heart rate: GLP-1 drugs can cause a slight increase in resting heart rate in some people (small pulse increase). This isn’t usually noticeable or harmful, but if you wear a fitness tracker you might see your resting pulse go up by a few beats per minute. It’s something your doctor might be aware of, especially if you have a history of certain heart rhythm issues. Generally, the benefits (like improved cardiovascular risk factors from weight loss) outweigh a minor rise in heart rate, but it’s noted for completeness.

• Elevated pancreatic enzymes: Blood tests in trials sometimes showed higher amylase or lipase (pancreatic enzymes) in people on Mounjaromedwayswaleformulary.co.uk. On their own, this doesn’t cause symptoms and usually isn’t problematic unless accompanied by pancreatitis symptoms. It’s just a lab observation.

• Calcitonin levels: Tirzepatide can cause a slight increase in blood calcitonin levels (a hormone produced by the thyroid) in some patientsmedicines.org.uk. This is related to the thyroid C-cell activation seen in animal studies. The levels observed in humans have not indicated thyroid cancer, but doctors may check this if there’s ever a concern. If you have any neck swelling, difficulty swallowing, or persistent hoarseness (potential thyroid-related symptoms), inform your doctor. These are precautionary measures for thyroid safety. Thus far, no cases of medullary thyroid carcinoma have been attributed to Mounjaro in humans, but vigilance is maintained due to the theoretical risk.

Remember, your doctor or pharmacist will give you a Patient Information Leaflet with a comprehensive list of side effects. It’s a good idea to read it and keep it handy. The leaflet will categorize side effects by frequency and provide guidance.

Most people tolerate Mounjaro well, especially after the first few weeks. In real-world use, the dropout rate due to side effects is relatively low – meaning the majority are able to continue therapy. If side effects do become troublesome, don’t suffer in silence: reach out to your healthcare provider. There may be remedies (like anti-nausea tablets, or adjusting the dose schedule) to help you. Sometimes taking the injection at night helps, so you sleep through the peak nausea period. Also, simple dietary adjustments can make a big difference in managing GI symptoms (e.g., eat slowly, avoid very large meals, limit alcohol which can irritate the stomach).

And importantly, report any serious or unexpected side effects. In the UK, you can report side effects using the Yellow Card scheme (either online or via an app)gov.uk. This helps regulators monitor the medication’s safety as it’s a relatively new treatment (see “Black triangle” in the safety notes below).

Interactions and important warnings

Before starting Mounjaro, it’s crucial to review your current medications and health conditions with the doctor or pharmacist, because there are some interactions and warnings to consider:

• Stomach-emptying and oral medications: Tirzepatide slows gastric emptying, meaning pills and capsules may sit longer in your stomach before being absorbed. This usually isn’t a big problem, but it could affect the absorption of certain oral medicinesmedwayswaleformulary.co.uk. For most standard medications, no dose adjustment is needed. However, for medications that require precise timing or blood levels (for example, certain thyroid medications, antibiotics, anticonvulsants, or the contraceptive pill), this delay could theoretically reduce their effectiveness. The main known issue is with oral contraceptive pills (see next point). For other drugs like warfarin (a blood thinner) or digoxin (for heart conditions), your doctor might be a bit more watchful when you start Mounjaro. If you are on Warfarin, an extra INR check may be done after starting tirzepatide to ensure levels remain stable.

• Oral contraceptives (the pill): Because of the above effect, Mounjaro may reduce the efficacy of oral contraceptive pills in overweight/obese patients. Essentially, if the pill isn’t absorbed at the usual rate, hormone levels could be lower and it might not protect against pregnancy as well. The advice is that women on oral contraception should use an additional barrier method (e.g., condoms) or switch to a non-oral form of contraception (like the patch, ring, or coil) for at least 4 weeks after starting Mounjaro and 4 weeks after each dose increase. This precaution helps ensure you remain protected from pregnancy. If you have a normal BMI and are on the pill, this is less of a concern, but for those with higher BMI on weight-loss doses, it’s a recommended step. Discuss with your healthcare provider about contraception when starting Mounjaro; they may suggest a more reliable method to avoid any risk of unplanned pregnancy.

• Other diabetes medications: If you are already on medication for diabetes:

  • Insulin or sulfonylureas (e.g., gliclazide): These can cause low blood sugar, and Mounjaro on its own can also lower glucose (especially in diabetics). The combination could push sugars too low. Therefore, your doctor will likely reduce the dose of insulin or sulfonylurea when you start Mounjaro. You’ll be given guidance to monitor your blood sugars closely. Never adjust your insulin without medical advice, but do follow any new plan your doctor provides. Be alert for hypoglycemia signs as discussed.

  • Metformin, SGLT2 inhibitors (e.g., dapagliflozin): These are generally fine to continue with Mounjaro. No interaction issues, and they don’t cause hypos by themselves, so they may be left unchanged.

  • DPP-4 inhibitors (e.g., sitagliptin) or other GLP-1 RAs (e.g., liraglutide/semaglutide): These work in a similar pathway, and using them with Mounjaro is usually not necessary or recommended (no added benefit, more side effects). Your prescriber will typically stop these other incretin-based therapies before starting Mounjaro to avoid duplicate therapy.

  • Blood sugar monitoring: If you have diabetes, as you lose weight and improve diet on Mounjaro, your blood sugar levels may improve a lot – which is great, but you might need adjustments in all diabetes meds. Keep close contact with your diabetes nurse/doctor. They might check your HbA1c every few months and adjust treatment accordingly.

• Pancreatitis risk: We mentioned pancreatitis in side effects, but to reiterate as a warning: if you have a history of pancreatitis, Mounjaro should be used cautiously if at all. And if you develop symptoms of pancreatitis (severe persistent abdominal pain, etc.), stop the medication and seek medical help. Do not restart unless pancreatitis is ruled out and your doctor says it’s okay. Typically, confirmed pancreatitis means no further use of this drug class.

• Thyroid tumors: Again, while human risk is not confirmed, there is a theoretical risk of medullary thyroid carcinoma with this class of drug (based on rodent studies). Do not use Mounjaro if you have personal/family history of MTC or MEN2 (as noted earlier). For everyone on Mounjaro, be mindful of thyroid-related symptoms (like a neck lump or persistent hoarseness). This is more of a long-term precaution; no cases have been reported, but safety monitoring is ongoing.

• Kidney function and dehydration: If you have moderate to severe kidney disease, you can usually still use Mounjaro (no dose change needed), but we carefully watch for dehydration. Repeated vomiting or diarrhea can worsen kidney function or even precipitate acute kidney injury in those with compromised kidneys. The key is to stay hydrated. If you cannot keep fluids down, seek medical advice early. Patients with kidney issues should also avoid NSAIDs and other nephrotoxic things while dehydrated. In summary, Mounjaro doesn’t directly harm kidneys, but dehydration can – so prevent it.

• Liver function: No significant interactions or issues have been seen with liver impairment. Just inform your doctor if you have liver disease so they can monitor overall health as you lose weight (weight loss itself often improves fatty liver).

• Other medications: Always list all medications, supplements, or herbal remedies you take when consulting for a Mounjaro prescription. While tirzepatide doesn’t have many drug-drug interactions (it’s not metabolized by CYP enzymes, for instance), it’s good practice. For example, if you’re on something like Levothyroxine for hypothyroidism, weight changes could affect your dose requirement; or if you’re on blood pressure pills, losing weight might lower your BP and require adjustments. These aren’t direct interactions with Mounjaro, but part of the holistic management of your health.

• Alcohol: There’s no direct contraindication with moderate alcohol use. However, alcohol can irritate the stomach (which may not mix well if you’re having nausea) and can affect blood sugar levels. If you have diabetes, be cautious with alcohol as usual. And if you find alcohol triggers appetite or unhealthy eating for you, you might want to limit it to maximize your weight loss efforts. Also, avoid drinking immediately after your shot if you’re feeling a bit queasy.

• Driving and using machines: Mounjaro itself shouldn’t impair your ability to drive. But if you experience side effects like dizziness or if you are a diabetic on insulin and at risk of hypos (low sugar can impair concentration), be careful. Don’t drive if you feel faint or weak.

In general, important warnings include: keep up with follow-ups, report any unusual symptoms, and stick to the plan. Mounjaro is a powerful medication and part of a medical weight management program – you will get the best and safest results by staying engaged with the healthcare team, rather than treating it as a stand-alone quick fix.

Lastly, because Mounjaro is a new medication for weight loss, it carries a “black triangle” symbol in the UK (▼). This indicates it’s under extra monitoring by regulatory agencies. Patients and healthcare professionals are encouraged to report any side effects. This doesn’t mean it’s unsafe – it passed clinical trials and approval – it’s simply a way to ensure ongoing safety data collection. We’ll discuss more on regulatory notes below.

Storage and handling

Proper storage of your Mounjaro pens will ensure the medication stays effective and safe to use. Here are the key points for storing and handling Mounjaro:

• Refrigeration: Unused Mounjaro pens should be kept in the refrigerator at 2°C to 8°C (36°F to 46°F). Store them in their original packaging to protect from light. Do not place them near the freezer compartment where temperatures might drop too low. Do not freeze the pens. Freezing can damage the solution. If a pen accidentally freezes, do not use it – dispose of it and use a new one.

• Room temperature use: Mounjaro pens can be stored at room temperature (up to 30°C or 86°F) for a limited time if needed. For example, if you are travelling or don’t have access to a fridge, it’s permissible to keep the pen out. In-use Mounjaro pens or pens removed from the fridge may be kept at room temp for up to 30 days After 30 days at room temp, any pen that has not been used must be discarded. This means if you take a pen out and leave it in a drawer, be mindful of that expiration. (Tip: write the date you took it out on the box.)

• Keep away from heat and light: Don’t store the pens in a hot car, in direct sunlight, or near a radiator. High temperatures can degrade the medication. Similarly, avoid excessive agitation (though normal handling is fine; it’s not overly fragile).

• Each pen is single-use: Unlike some insulin pens that can be used for multiple injections, the Mounjaro pens are single-dose disposable pens. Each pen comes pre-filled with more liquid than needed for one dose, but the device is engineered to inject a fixed dose and then you discard the entire pen (needle and all) after that injection. Do not attempt to reuse a pen for another dose – there will be leftover liquid, but it’s not meant for reuse, and the pen will lock after injection. Always use a new pen for each weekly dose. (This is an important distinction; each box of Mounjaro typically contains 4 pens, which is a 4-week supply at the given dose.)

• Check expiry dates: Mounjaro pens have expiration dates on them. Do not use beyond that date. If your medication expires or if you have pens remaining that you no longer need, return them to a pharmacy for safe disposal rather than using them.

• Before injecting: Inspect the solution through the pen’s window. It should be clear and colorless, with no particles. If you see cloudiness, discoloration, or particles, do not use that pen – get a new one and return the questionable pen to the pharmacy.

• After injecting – disposal: Used pen devices should be disposed of in a sharps container. Do not throw them in the regular bin where someone could get poked. We (or your GP pharmacy) can provide a yellow sharps bin for you. After you use the pen, put it (with the needle attached) into the sharps bin. When the bin is full, it can be returned to a pharmacy or appropriate facility for disposal. If you don’t have a sharps container immediately, you could temporarily use a thick plastic container (like an empty laundry detergent bottle) with a lid as a short-term measure – but ideally, get a proper sharps bin.

• Traveling with Mounjaro:

  • If you’re taking a trip, plan ahead. Keep your pens in their original box with you in hand luggage (the cargo hold might be too cold or hot). Airport security is used to people carrying injectable medications – just declare it if asked. It’s helpful to have a copy of your prescription or a doctor’s note when flying, to avoid issues with security.

  • If travelling a short distance, you can take the pen out of the fridge shortly before use so it warms up a bit (many find injecting at room temp more comfortable than injecting straight from a cold pen).

  • If going somewhere without refrigeration for more than a few days, remember the 30-day room temp rule. If longer, you might need a cool bag/insulated pack. Also, keep it out of direct sun.

• Keep out of reach of children: Always store medication where kids or pets cannot get to it. The pens have caps, but a curious child could still cause a needle stick or waste the dose.

• Do not share pens: This medication is prescribed to you only. Even if someone else has a similar condition, never share your pens or use someone else’s. Aside from dosing differences, there’s a risk of infection transmission with shared injection devices.

Proper storage ensures that the medication remains effective for its full shelf life. If you have any leftover pens (for instance, if your dose increased and you have some of the lower dose pens not used), speak to your provider or pharmacy – do not use a lower dose pen twice to equal a higher dose, as that’s not the recommended usage and could lead to dosing errors.

If you ever have any doubts about whether a pen has been stored correctly (say it was left out overnight by accident), check with a pharmacist. When in doubt, it’s often safer to replace it, because using a degraded medication might mean you don’t get the full effect.

Key safety and regulatory notes

Mounjaro (tirzepatide) represents a significant advancement in weight loss treatment, and with that comes close oversight by health authorities. Here are some key safety and regulatory points to be aware of:

• Prescription-only medicine (POM): Mounjaro is not available over the counter. It must be prescribed by a qualified healthcare professional after an appropriate assessment of your condition. Any website or source offering it without a prescription is not legitimate and could be dangerous. Always obtain it through a reputable pharmacy or clinic (like our MedCare Health Clinic & Pharmacy service, or NHS pathways if eligible).

• MHRA approval in the UK: The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) officially authorized Mounjaro for weight management in adults in November 2023gov.uk. This was a notable decision, as it allowed tirzepatide (previously only for diabetes) to be used for obesity treatment. The approved indication is: adults with BMI ≥ 30, or BMI 27–29.9 with at least one weight-related comorbidity, in conjunction with diet and exercisegov.uk. This means it has passed rigorous reviews for safety, quality, and efficacy for those groups. The MHRA fast-tracked this approval given the public health importance of new obesity treatments.

• NICE guidance: The National Institute for Health and Care Excellence (NICE) in the UK provides recommendations on when the NHS should use treatments. In December 2024, NICE published technology appraisal TA1026, recommending tirzepatide as an option for managing obesity only if certain criteria are metncbi.nlm.nih.gov:

  • Specifically, NICE recommends it for adults with BMI ≥ 35 kg/m² and at least one weight-related comorbidity (or a lower BMI threshold of ≥32.5 for certain ethnic groups at higher risk)ncbi.nlm.nih.gov. This is slightly stricter than the MHRA’s licensing. It reflects decisions about cost-effectiveness and targeting those at highest risk in the NHS.

  • NICE also suggests evaluating treatment at 6 months to ensure sufficient weight loss (≥5%) is achieved and only continuing if it’s beneficial.

  • For now, NHS access to Mounjaro will be through specialist weight management services and a phased introduction due to budget and capacity constraints.

  • Private prescription services (like ours) are not bound by the NHS funding criteria, but we still adhere to the licensed indications and ensure it’s appropriate case by case. So even if you don’t fit the narrow NHS criteria, you may still be able to receive Mounjaro privately if it’s clinically suitable and safe for you.

  • The bottom line: NICE’s backing confirms Mounjaro’s effectiveness, but not everyone will get it on the NHS immediately. Many patients are turning to private providers for access.

• Black Triangle (▲) designation: As mentioned, Mounjaro carries a black triangle symbol in its labelling in the UK. This indicates it is a new medicine under additional monitoring by regulatory agencies. For you, this mainly means: if you experience any side effects, especially anything unexpected, you are encouraged to report them via the Yellow Card scheme (which can be done online or through an app)gov.uk. Healthcare professionals will also be reporting adverse events diligently. This extra monitoring helps the MHRA collect data on real-world use and ensure any rare issues are caught early. Don’t be alarmed by the black triangle – it doesn’t mean the drug is unsafe; it’s a standard practice for all newly approved medications (to build a robust safety profile as usage grows).

• Global context: Tirzepatide is also approved in other regions (for example, the FDA in the United States initially approved it for diabetes, and in late 2023 the FDA approved it under the name Zepbound for obesity in the US). In the UK and EU, the brand name “Mounjaro” covers both uses (diabetes and weight loss). So if you hear about “Zepbound,” know that it’s essentially the same medication (tirzepatide) but branded differently in the U.S. for weight management. For all practical purposes, Mounjaro in the UK is the product you will get for weight loss. It contains the same tirzepatide and comes in the same pen device.

• Quality and authenticity: Because medications like Mounjaro have garnered a lot of attention, there is unfortunately a risk of counterfeit products in the market. Only obtain Mounjaro from a regulated UK pharmacy. Each pen or box will have batch numbers and holograms to show authenticity. If something ever seems off (packaging in a foreign language without English PIL, etc.), check with a pharmacist. Never be tempted by drastically cheaper offers from unknown sources – if it sounds too good to be true, it probably is fake. Counterfeit injectables can be ineffective or harmful. Our pharmacy sources directly from the official supply chain, so you can trust the product’s authenticity.

• Ongoing monitoring and research: Post-approval, studies continue to look at tirzepatide’s long-term effects. So far, results are very positive not just for weight loss but also in improvements in blood pressure, cholesterol, and even indicators of cardiovascular health. A trial in 2022 (SURMOUNT-1) showed many patients’ prediabetes reverted to normal with the weight loss, and other metabolic improvements were noted. There’s an ongoing cardiovascular outcomes trial (SURPASS-CV) to see if tirzepatide reduces heart attacks/strokes in those with diabetes. Early indications suggest potential benefits. All this means you’re using a cutting-edge therapy that is likely doing more than just helping you shed pounds – it could be improving your overall metabolic health.

• Duration of therapy: There isn’t a hard-and-fast rule for how long you’ll stay on Mounjaro. Some may use it for a year to kick-start weight loss and then stop if they reach goals, while others might need it longer to maintain benefits. Current guidance often suggests evaluating at 6 months and 12 months. NHS guidance (for Wegovy, a similar drug) limits use to 2 years in specialist services, but for tirzepatide it’s not explicitly stated yet – it will likely be similar. Privately, a doctor might continue it as long as needed provided there are no safety concerns and you’re monitored. When stopping, a plan should be in place (maybe transitioning to another maintenance strategy or very careful lifestyle adherence) to prevent weight rebound.

• Patient support and lifestyle: Using Mounjaro should come with support. At our clinic, we emphasise that medication is one part of the journey. We (like Boots Online Doctor and others) encourage dietary coaching, exercise programs, or partnerships with services like WeightWatchers. Take advantage of any nutritional counseling or fitness guidance offered. Not only will this improve your results, but it sets you up with habits to maintain your healthier weight if the medication is ever stopped. Many patients find that the lessons learned during this period – mindful eating, regular physical activity, behavioral changes – are invaluable.

• Safety reminders: While on treatment, keep in regular contact with your healthcare provider. If you experience any significant side effect or health issue, let them know. They may do occasional blood tests – for example, checking your blood sugar, liver function, kidney function, thyroid function, etc., especially if you have relevant medical history. These are precautionary and to ensure all is well as you lose weight. Also, if you visit any other doctor or a hospital, make sure to tell them you are on tirzepatide, in case it’s relevant to your care (for instance, if you were having surgery, they may want to adjust insulin dosing or be aware of your slowed digestion).

• Empowerment: Weight loss can significantly improve health markers, but it’s not a magic cure-all. Continue to take care of your overall health – for instance, keep taking any other prescribed medications (for blood pressure, cholesterol, etc.) unless told otherwise, attend health screenings, and nurture your mental well-being too. Sometimes, as people lose a lot of weight, they encounter unexpected emotions or challenges (like body image changes or plateaus). Our clinic is here to support you through the process. Don’t hesitate to reach out for help or advice at any stage.

In closing, Mounjaro (tirzepatide) is a promising and powerful tool in the fight against obesity. It offers hope to individuals who have struggled to lose weight and keep it off. By understanding how to use it properly and being aware of its effects, you can make the most of this treatment safely. Always follow the guidance of healthcare professionals, and combine the medication with healthy lifestyle changes for the best outcome. With patience and commitment, many patients see life-changing results on Mounjaro – not just in the numbers on the scale, but in their overall health, confidence, and quality of life.

If you think Mounjaro might be right for you, or if you have any further questions, feel free to contact MedCare Health Clinic & Pharmacy. Our medical team can provide a personalised consultation, discuss whether you’re a suitable candidate, and guide you through the treatment process step by step. We are dedicated to helping you achieve your weight loss goals safely and effectively with compassionate support throughout your journey.

Citations:

• MHRA Press Release – “MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss” (8 Nov 2023)gov.ukgov.uk

• MHRA Press Release – Mechanism and usage detailsgov.ukgov.uk

• MHRA Press Release – SURMOUNT trial results and side effectsgov.ukgov.ukgov.uk

• Patient Information Leaflet (Mounjaro) – Serious side effects and frequenciesmedicines.org.ukmedicines.org.ukmedicines.org.uk

• NHS Kent & Medway Formulary – Storage and contraceptive guidancemedwayswaleformulary.co.ukmedwayswaleformulary.co.uk

• NHS Kent & Medway Formulary – Precautions: pregnancy, pancreatitis, GI diseasemedwayswaleformulary.co.ukmedwayswaleformulary.co.ukmedwayswaleformulary.co.uk

• NICE Technology Appraisal TA1026 (Dec 2024) – Eligibility criteriancbi.nlm.nih.govncbi.nlm.nih.gov